| DIRECT COMPETITOR COMPARISON | |
| RGDX | CLDA | GHDX | DGX | Industry | | Market Cap: | 22.03M | 414.05M | 542.16M | 10.77B | 62.33M | | Employees: | 50 | 161 | 387 | 42,800 | 70 | | Qtrly Rev Growth (yoy): | 15.50% | 26.80% | 40.50% | 3.90% | 18.90% | | Revenue (ttm): | 7.14M | 12.74M | 141.20M | 7.41B | 12.73M | | Gross Margin (ttm): | 38.47% | 47.03% | 75.88% | 42.16% | 50.63% | | EBITDA (ttm): | -9.36M | -68.48M | -5.46M | 1.61B | -1.76M | | Oper Margins (ttm): | -139.08% | -558.18% | -8.32% | 18.18% | -3.83% | | Net Income (ttm): | -11.01M | -82.79M | -11.40M | 717.54M | N/A | | EPS (ttm): | -0.917 | -3.529 | -0.400 | 3.774 | N/A | | P/E (ttm): | N/A | N/A | N/A | 15.44 | 23.64 | | PEG (5 yr expected): | N/A | N/A | N/A | 1.21 | 1.36 | | P/S (ttm): | 3.09 | 32.50 | 3.84 | 1.45 | 3.09 |
|
| CLDA = Clinical Data, Inc. | | GHDX = Genomic Health Inc. | | DGX = Quest Diagnostics Inc. | | Industry = Diagnostic Substances | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | 0.00% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | 0.00% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | 0.00% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | 0.00% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | 0.00% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | 0.00% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | 0.00% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | 0.00% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | 0.00% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | 0.00% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | 0.00% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | 0.00% | 107.13B | 13.42 | | Sanofi-Aventis | SNY | 38.43 | 0.00% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | 0.00% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | 0.00% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | 0.00% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | 0.00% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | DGX | | Leaders from Google, others to attend White House summit
Mon 6:50am -
Reuters | | • | DGX | | Leaders from Google, others to attend White House summit
Sun 6:11pm -
Reuters | | • | DGX | | ETF Sector Detector: Getting More Defensive
Wed, Nov 25 -
at Seeking Alpha | | • | DGX | | Feds seek rehearing of baseball drug list ruling
Wed, Nov 25 -
AP | | • | DGX | | Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference
Tue, Nov 24 -
PR Newswire | | • | GHDX | | Genomic Health to Present at Piper Jaffray Health Care Conference
Tue, Nov 24 -
PR Newswire | | • | CLDA | | Clinical Data, Inc. to Present at Piper Jaffray Health Care Conference
Tue, Nov 24 -
Business Wire | | • | DGX | | Swine flu may have hit one peak; more to come
Fri, Nov 20 -
at Reuters | | • | GHDX | | 4-Star Stocks on the Upswing
Fri, Nov 20 -
at Motley Fool | | • | CLDA | | Clinical Data, Inc. Initiates Phase III Trial of Stedivaze for Cardiac Stress Testing
Wed, Nov 18 -
Business Wire | | • | CLDA | | Clinical Data, Inc. Establishes Scientific Advisory Board for Cardiovascular Genetics
Tue, Nov 17 -
Business Wire | | • | CLDA | | Trading Overview for Sequenom Inc. Issued by StockPreacher.com
Tue, Nov 17 -
GlobeNewswire | | • | CLDA | | Clinical Data, Inc. Launches Genetic Test for Dilated Cardiomyopathy (DCM) at the 2009 American Heart Association Meeting
Mon, Nov 16 -
Business Wire | | • | GHDX | | GENOMIC HEALTH INC Financials
Fri, Nov 13 -
EDGAR Online Financials | | • | GHDX | | Mad Mail: Buy the Berkshire Hathaway Split?
Mon, Nov 9 -
at CNBC | | • | GHDX | | [video] Homework
Mon, Nov 9 -
at CNBC | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 0.00%
Competitors
